Skip to main navigation Skip to search Skip to main content

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)

    Project: Research

    Project Details

    StatusActive
    Effective start/end date11/11/20 → …